ICR to enter AI-powered cancer drug discovery partnership
Scientists at the ICR, London are set to enter a partnership to merge capabilities for designing precision drugs for cancer leveraging AI.
Scientists at the ICR, London are set to enter a partnership to merge capabilities for designing precision drugs for cancer leveraging AI.
What's Your Reaction?
